Measurement of platelet aggregation, independently of patient platelet count: a flow‐cytometric approach

Franco, 2015, Platelets at the interface of thrombosis, inflammation, and cancer, Blood, 126, 582, 10.1182/blood-2014-08-531582

Hersh, 1965, Causes of death in acute leukemia: a ten‐year study of 414 patients from 1954–1963, JAMA, 193, 105, 10.1001/jama.1965.03090020019005

Slichter, 2010, Dose of prophylactic platelet transfusions and prevention of hemorrhage, N Engl J Med, 362, 600, 10.1056/NEJMoa0904084

Vinholt, 2014, An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients, Eur J Haematol, 92, 367, 10.1111/ejh.12262

Cattaneo, 2013, Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the Platelet Physiology Subcommittee of SSC/ISTH, J Thromb Haemost, 11, 1183, 10.1111/jth.12231

De Cuyper, 2013, A novel flow cytometry‐based platelet aggregation assay, Blood, 121, e70, 10.1182/blood-2012-06-437723

Leinoe, 2004, Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia, Br J Haematol, 127, 76, 10.1111/j.1365-2141.2004.05156.x

Leinoe, 2005, Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function, Br J Haematol, 128, 526, 10.1111/j.1365-2141.2004.05335.x

Psaila, 2011, Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia, J Thromb Haemost, 9, 2302, 10.1111/j.1538-7836.2011.04506.x

Swerdlow, 2008

Rodeghiero, 2010, ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders, J Thromb Haemost, 8, 2063, 10.1111/j.1538-7836.2010.03975.x

Lordkipanidze, 2014, Characterization of multiple platelet activation pathways in patients with bleeding as a high‐throughput screening option: use of 96‐well Optimul assay, Blood, 123, e11, 10.1182/blood-2013-08-520387

Rubak, 2015, Investigation of platelet function and platelet disorders using flow cytometry, Platelets, 27, 66, 10.3109/09537104.2015.1032919

Shattil, 1985, Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation, J Biol Chem, 260, 11107, 10.1016/S0021-9258(17)39154-8

Kuypers, 1990, Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils, Eur J Immunol, 20, 501, 10.1002/eji.1830200307

Slichter, 2004, Relationship between platelet count and bleeding risk in thrombocytopenic patients, Transfus Med Rev, 18, 153, 10.1016/j.tmrv.2004.03.003

van Bladel, 2014, Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts, Blood, 123, 1556, 10.1182/blood-2013-08-519686

Iyu, 2011, Mode of action of P2Y(12) antagonists as inhibitors of platelet function, Thromb Haemost, 105, 96, 10.1160/TH10-07-0482

Iyu, 2011, Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist, Arterioscler Thromb Vasc Biol, 31, 416, 10.1161/ATVBAHA.110.219501

Chackalamannil, 2008, Discovery of a novel, orally active himbacine‐based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity, J Med Chem, 51, 3061, 10.1021/jm800180e

Peter, 1998, Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors, Blood, 92, 3240, 10.1182/blood.V92.9.3240

Armstrong, 2012, GPIIb/IIIa inhibitors: from bench to bedside and back to bench again, Thromb Haemost, 107, 808, 10.1160/TH11-10-0727

Weber, 2001, Differential inhibition of adenosine diphosphate‐ versus thrombin receptor‐activating peptide‐stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics, Blood, 98, 1619, 10.1182/blood.V98.5.1619

Gawaz, 2000, Incomplete inhibition of platelet aggregation and glycoprotein IIb–IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb–IIIa receptors, Thromb Haemost, 83, 915, 10.1055/s-0037-1613921

Frelinger, 2015, Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP, Blood, 126, 873, 10.1182/blood-2015-02-628461

Soderstrom, 2016, The effect of centrifugation speed and time on pre‐analytical platelet activation, Clin Chem Lab Med, 54, 1913, 10.1515/cclm-2016-0079

Peters, 2003, Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study, Circulation, 108, 1682, 10.1161/01.CIR.0000091201.39590.CB

Cannon, 2010, Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double‐blind study, Lancet, 375, 283, 10.1016/S0140-6736(09)62191-7